Discontinued — last reported Q3 '19
Citigroup Financing Receivables, Collectively Evaluated for Impairment decreased by 97.4% to $18.87B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 97.2%, from $684.81B to $18.87B. Over 5 years (FY 2020 to FY 2025), Financing Receivables, Collectively Evaluated for Impairment shows a downward trend with a -50.9% CAGR.
Growth in this segment indicates expansion in retail or standardized lending, while changes in impairment levels signal shifts in portfolio credit quality.
This metric represents the portion of financing receivables that are evaluated for impairment on a collective basis, typ...
Commonly used by retail and commercial banks to report on consumer loan portfolios.
bank_financing_receivables_collective_impairment| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $661.95B | $651.23B | $656.01B | $648.87B | $648.23B | $637.67B | $647.70B | $645.50B | $653.43B | $656.79B | $679.71B | $664.04B | $678.03B | $679.67B | $684.81B | $692.26B | $714.15B | $723.70B | $18.87B |
| QoQ Change | — | -1.6% | +0.7% | -1.1% | -0.1% | -1.6% | +1.6% | -0.3% | +1.2% | +0.5% | +3.5% | -2.3% | +2.1% | +0.2% | +0.8% | +1.1% | +3.2% | +1.3% | -97.4% |
| YoY Change | — | — | — | — | -2.1% | -2.1% | -1.3% | -0.5% | +0.8% | +3.0% | +4.9% | +2.9% | +3.8% | +3.5% | +0.8% | +4.3% | +5.3% | +6.5% | -97.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.